A detailed history of Ronald Blue Trust, Inc. transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 23,121 shares of CLBT stock, worth $426,582. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,121
Previous 22,223 4.04%
Holding current value
$426,582
Previous $355,000 20.56%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 16, 2025

BUY
$13.52 - $18.97 $12,140 - $17,035
898 Added 4.04%
23,121 $428,000
Q2 2025

Jul 24, 2025

BUY
$15.47 - $20.14 $23,158 - $30,149
1,497 Added 7.22%
22,223 $355,000
Q1 2025

Apr 21, 2025

SELL
$16.78 - $26.0 $8,390 - $13,000
-500 Reduced 2.36%
20,726 $402,000
Q4 2024

Jan 30, 2025

BUY
$16.52 - $22.52 $892 - $1,216
54 Added 0.26%
21,226 $467,000
Q4 2024

Jan 22, 2025

BUY
$16.52 - $22.52 $349,761 - $476,793
21,172 New
21,172 $466,000

Others Institutions Holding CLBT

About Cellebrite DI Ltd.


  • Ticker CLBT
  • Exchange NASDAQ
  • Sector Technology
  • Industry Software—Infrastructure
  • Shares Outstandng 189,648,992
  • Market Cap $3.5B
  • Description
  • Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...
More about CLBT
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.